How Orange Book Antitrust Scrutiny is Intensifying
Abbvie Defeats Novel Antitrust Claims Against Humira Patent Estate ...
... Orange Book patent. Third, private plaintiffs and the Federal Trade Commission will continue to scrutinize and seek to challenge biologics ...
Instead of direct financial harm to consumers, critics argue the companies use their market power to steer business to their own operations, ...
The Current Status of FTC's Orange Book Listings Challenge
On September 14, 2023, the U.S. Federal Trade Commission issued a "Policy Statement" declaring that "improper" pharmaceutical patent ...
The company is facing simultaneous challenges in both chambers of Congress, as well as from states. Legislation that would reform some aspects ...
The FTC's Criticism of “Junk” Orange Book Filings - Ropes & Gray LLP
In light of the heightened regulatory scrutiny surrounding drug pricing, branded drug manufacturers should expect, and prepare for, a ...